ERBA Diagnostics (ERB) Tops Q2 EPS by 1c

ERBA Diagnostics (NYSE: ERB) reported Q2 EPS of ($0.01), $0.01 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $5.9 million versus the consensus estimate of $5.16 million.

For earnings history and earnings-related data on ERBA Diagnostics (ERB) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• StoneCo (STNE) Reports In-Line Q2 EPS
• Capricor Therapeutics (CAPR) Misses Q2 EPS by 10c